Funds · GANX

Who owns GANX?

Institutional ownership of Gain Therapeutics Inc. from Form 13F, Q2 2026

50 institutional managers reported holding Gain Therapeutics Inc. (GANX) in Form 13F filings for Q2 2026, with 9,229,420 shares worth $18.6M. The largest reported holder was Marshall Wace, LLP. Managers that filed both quarters added a net 1,034,421 shares (+12.6%). 12 opened new positions and 4 sold out.

Funds holding
50
Value held
$18.6M
New / sold out
12 / 4
Net shares, same filers
+12.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of GANX

FundValueShare of 13F holdingsSharesMove
Marshall Wace, LLP$3.9M20.8%1,923,546Added
Cambridge Investment Research Advisors, Inc.$2.3M12.3%1,137,290Added
Potomac Capital Management, Inc.$1.9M10.3%946,400Trimmed
Gsa Capital Partners LLP$1.3M6.8%632,131Added
DME Capital Management, LP$1.1M6.1%566,130Unchanged
Jones Financial Companies LLLP$1.1M6.6%608,592Trimmed
Vanguard Capital Management LLC$975K5.2%480,269Added
Geode Capital Management, LLC$921K4.9%453,501Added
BlackRock, Inc.$558K3.0%274,957Added
Vanguard Fiduciary Trust Co$470K2.5%231,534Added
UBS Group AG$436K2.3%215,012Trimmed
Stratos Wealth Partners, LTD.$406K2.2%200,000Added
Cresset Asset Management, LLC$325K1.7%160,000Unchanged
State Street Corp$320K1.7%157,537Unchanged
Citadel Advisors LLC$314K1.7%154,524Added
Squarepoint Ops LLC$277K1.5%136,359New
Morgan Stanley$256K1.4%125,972Trimmed
LPL Financial LLC$238K1.3%117,251Added
Northern Trust Corp$197K1.1%97,013Trimmed
Susquehanna International Group, LLP$159K0.8%78,206Trimmed
Commonwealth Equity Services, LLC$119K0.6%58,456Added
Jane Street Group, LLC$113K0.6%55,628Trimmed
XTX Topco Ltd$112K0.6%55,294New
Prelude Capital Management, LLC$73K0.4%35,820Unchanged
Benedict Financial Advisors Inc$71K0.4%35,000Added

Share of 13F holdings is each fund's shares as a share of the 9,229,420 GANX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $3.5M and sold $1.4M; 15 added and 9 trimmed.

Questions about GANX ownership

Who owns GANX stock?
50 institutional investment managers reported GANX positions in their Form 13F filings for Q2 2026, holding 9,229,420 shares worth $18.6M in total. Marshall Wace, LLP reported the largest position.
Are funds buying or selling GANX?
In Q2 2026, 12 managers opened new GANX positions, 15 added, 9 trimmed and 4 sold out. Managers that filed in both quarters added a net 1,034,421 shares.
How current is this GANX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to GANX by CUSIP. Options are left out. GANX news and filings · GANX insider trades · Top funds